m+Medelevator.RU
← Поиск публикаций
Fertility and sterility · 2004

Effect of angiotensin-converting enzyme-inhibiting therapy on the expression of vascular endothelial growth factor in hyperstimulated rat ovary.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ozcakir Hasan Tayfun, Giray Seren Gulsen, Ozbilgin Mahmut Kemal, Inceboz Umit Sungurtekin, Caglar Husnu

Аннотация

OBJECTIVE: To determine the effect of angiotensin-converting enzyme-inhibiting therapy on the expression of vascular endothelial growth factor (VEGF) in the hyperstimulated rat ovary.

DESIGN: Experimental study.

SETTING: University animal research laboratory.

ANIMAL(S): Thirty Wistar albino adult female rats were studied; 20 rats were stimulated with gonadotropins (groups 1 and 2), and 10 were controls (group 3). Ten of the stimulated rats received additional treatment with enalapril (group 2).

INTERVENTION(S): At the end of the treatment period, rat ovaries were subjected to immunohistochemical staining with anti-VEGF antibodies.

MAIN OUTCOME MEASURE(S): VEGF staining intensity was graded semiquantitatively, and the H-score was calculated by light microscopic examination of the groups.

RESULT(S): VEGF expression was found to be significantly higher in the endothelium and stroma in groups 1 and 2 compared with group 3. Although VEGF immunoreactivity was lower in the stimulation regimen plus enalapril group compared with the stimulation regimen-only group, the difference was insignificant.

CONCLUSION(S): Enalapril does not seem to have a significant effect on VEGF expression in the hyperstimulated rat ovary. Because angiotensin II exerts its multiple actions via specific receptors, there may be other factors, such as a receptor blockade, that contribute to the VEGF expression.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты